Point72 Hong Kong’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-11,184
Closed -$15K 2304
2022
Q2
$15K Buy
+11,184
New +$16.6K ﹤0.01% 1611
2021
Q4
Sell
-13,672
Closed -$68K 2272
2021
Q3
$68K Buy
+13,672
New +$78.7K ﹤0.01% 1445
2020
Q4
Sell
-653
Closed -$2K 1977
2020
Q3
$2K Sell
653
-397
-38% -$1.88K ﹤0.01% 1122
2020
Q2
$5K Buy
+1,050
New +$3.57K ﹤0.01% 1041
2019
Q1
Sell
-2,646
Closed -$17K 1221
2018
Q4
$17K Buy
+2,646
New +$29.7K 0.01% 476
2016
Q2
Sell
-1,715
Closed -$58K 635
2016
Q1
$58K Sell
1,715
-1,413
-45% -$44.5K 0.11% 150
2015
Q4
$93K Buy
+3,128
New +$105K 0.31% 98

Other funds holding PGEN

Point72 Hong Kong's PGEN Position: Q3 2022 in Review

Point72 Hong Kong sold out of Precigen (PGEN) in Q3 2022, closing a stake of 11,184 shares — an estimated $15K sold.

Point72 Hong Kong first reported a position in PGEN in Q4 2015 and held it in 7 quarters. The position peaked at $93K in Q4 2015. 165 funds tracked by Wall St. Rank hold PGEN as of Q3 2022.

  • Point72 Hong Kong reported no remaining Precigen position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 11,184 Precigen shares in Q3 2022, an estimated $15K.
  • Point72 Hong Kong first reported a position in Precigen in Q4 2015 and held it in 7 quarters.
  • Point72 Hong Kong's Precigen position peaked at $93K in Q4 2015.
  • 165 funds tracked by Wall St. Rank held Precigen as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.